Biodexa Pharmaceuticals Plc (BDRX)
1.25
-0.07
(-5.30%)
USD |
NASDAQ |
May 02, 16:00
1.24
-0.01
(-0.80%)
After-Hours: 17:15
Biodexa Pharmaceuticals Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 100.00% |
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 100.00% |
October 31, 2023 | 99.99% |
September 30, 2023 | 99.99% |
August 31, 2023 | 99.99% |
July 31, 2023 | 99.99% |
June 30, 2023 | 99.99% |
May 31, 2023 | 99.99% |
April 30, 2023 | 99.97% |
March 31, 2023 | 99.95% |
February 28, 2023 | 99.80% |
January 31, 2023 | 99.77% |
December 31, 2022 | 99.77% |
November 30, 2022 | 99.66% |
October 31, 2022 | 99.66% |
September 30, 2022 | 99.66% |
August 31, 2022 | 99.66% |
July 31, 2022 | 99.66% |
June 30, 2022 | 99.66% |
May 31, 2022 | 99.66% |
April 30, 2022 | 99.66% |
Date | Value |
---|---|
March 31, 2022 | 99.66% |
February 28, 2022 | 99.66% |
January 31, 2022 | 99.66% |
December 31, 2021 | 99.66% |
November 30, 2021 | 99.66% |
October 31, 2021 | 99.66% |
September 30, 2021 | 99.66% |
August 31, 2021 | 99.66% |
July 31, 2021 | 99.66% |
June 30, 2021 | 99.66% |
May 31, 2021 | 99.66% |
April 30, 2021 | 99.66% |
March 31, 2021 | 99.66% |
February 28, 2021 | 99.66% |
January 31, 2021 | 99.66% |
December 31, 2020 | 99.66% |
November 30, 2020 | 99.66% |
October 31, 2020 | 99.66% |
September 30, 2020 | 99.66% |
August 31, 2020 | 99.66% |
July 31, 2020 | 99.66% |
June 30, 2020 | 99.66% |
May 31, 2020 | 99.66% |
April 30, 2020 | 99.66% |
March 31, 2020 | 99.66% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.51%
Minimum
May 2019
100.00%
Maximum
Nov 2023
99.60%
Average
99.66%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Adaptimmune Therapeutics PLC | 96.57% |
NuCana PLC | 98.68% |
Autolus Therapeutics PLC | 96.58% |
Mereo BioPharma Group PLC | 94.92% |
Bicycle Therapeutics PLC | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -103.14 |
Beta (5Y) | 1.526 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.2% |
Historical Sharpe Ratio (5Y) | -0.86 |
Historical Sortino (5Y) | -1.349 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 51.85% |